VYGR · Voyager Therapeutics, Inc. · Share Buybacks
$1.70
-0.06 (-3.41%)
At close · Nov 12
Return incl. dividend (before tax)
Q4 2024 earnings call transcript
Market Cap
$105.79M
Shares
62.23M
Volume · Nov 12
1.39M
Avg daily vol (3M)
743.08K
You came from your AI assistant. Add Equibles to it and ask about this data directly, free.
Share-repurchase activity from the company's own XBRL filings — cash spent buying back common stock per fiscal year and per recent quarter, share counts where the company tagged them, and the buyback program's authorization — paired with the company's at-the-market (ATM) equity offering programs, the dilution side of the same picture. Repurchase amounts come exclusively from tagged SEC data; program figures with no tagged equivalent (untagged authorizations and all ATM figures) are read from the filing's own text and shown only after verification.
Remaining Authorization
131,470 shares
as of 2023-12-31
· not restated in filings since 2024-02-28
Equity Offering (ATM) Programs
| Program Established | Last Amended | Capacity | Remaining | Runs Through | Source |
|---|---|---|---|---|---|
| 2025-11-10 | — | $100,000,000 | — | — | 10-K , filed 2026-03-09 |
Key facts
CIK
1640266
CUSIP
92915B106
13F (30d)
81 filings
59 filers
Visit website
Investor relations